| Product Code: ETC10939563 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Hong Kong continued to rely on vaccine imports from top countries such as Australia, Germany, USA, Portugal, and Switzerland. The market remained highly concentrated, indicating limited diversification in vaccine sources. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.35%, reflecting a decline in demand or supply disruptions. Moreover, the sharp decline in growth rate from 2023 to 2024 at -52.43% suggests significant challenges or shifts in the market dynamics. Hong Kong`s import trends in vaccines demonstrate ongoing reliance on key trading partners amid changing market conditions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Vaccine Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Hong Kong Vaccine Market - Industry Life Cycle |
3.4 Hong Kong Vaccine Market - Porter's Five Forces |
3.5 Hong Kong Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Hong Kong Vaccine Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
3.7 Hong Kong Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
3.8 Hong Kong Vaccine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.9 Hong Kong Vaccine Market Revenues & Volume Share, By Technology, 2022 & 2032F |
4 Hong Kong Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Hong Kong Vaccine Market Trends |
6 Hong Kong Vaccine Market, By Types |
6.1 Hong Kong Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Hong Kong Vaccine Market Revenues & Volume, By Preventive Vaccines, 2022 - 2032F |
6.1.4 Hong Kong Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2022 - 2032F |
6.1.5 Hong Kong Vaccine Market Revenues & Volume, By DNA Vaccines, 2022 - 2032F |
6.2 Hong Kong Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Vaccine Market Revenues & Volume, By Influenza, 2022 - 2032F |
6.2.3 Hong Kong Vaccine Market Revenues & Volume, By COVID19, 2022 - 2032F |
6.2.4 Hong Kong Vaccine Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.3 Hong Kong Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Vaccine Market Revenues & Volume, By Pediatrics, 2022 - 2032F |
6.3.3 Hong Kong Vaccine Market Revenues & Volume, By Adults, 2022 - 2032F |
6.3.4 Hong Kong Vaccine Market Revenues & Volume, By Geriatrics, 2022 - 2032F |
6.4 Hong Kong Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Vaccine Market Revenues & Volume, By Intramuscular, 2022 - 2032F |
6.4.3 Hong Kong Vaccine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.4.4 Hong Kong Vaccine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.5 Hong Kong Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Hong Kong Vaccine Market Revenues & Volume, By mRNAbased, 2022 - 2032F |
6.5.3 Hong Kong Vaccine Market Revenues & Volume, By Viral Vector, 2022 - 2032F |
6.5.4 Hong Kong Vaccine Market Revenues & Volume, By Protein Subunit, 2022 - 2032F |
7 Hong Kong Vaccine Market Import-Export Trade Statistics |
7.1 Hong Kong Vaccine Market Export to Major Countries |
7.2 Hong Kong Vaccine Market Imports from Major Countries |
8 Hong Kong Vaccine Market Key Performance Indicators |
9 Hong Kong Vaccine Market - Opportunity Assessment |
9.1 Hong Kong Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Hong Kong Vaccine Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
9.3 Hong Kong Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
9.4 Hong Kong Vaccine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.5 Hong Kong Vaccine Market Opportunity Assessment, By Technology, 2022 & 2032F |
10 Hong Kong Vaccine Market - Competitive Landscape |
10.1 Hong Kong Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Hong Kong Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here